Retraction: FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

Stephanie K. Watkins, Ziqiang Zhu, Elena Riboldi, Kim A. Shafer-Weaver, Katherine E R Stagliano, Martha M. Sklavos, Stefan Ambs, Hideo Yagita, Arthur A. Hurwitz

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)2179
Number of pages1
JournalJournal of Clinical Investigation
Volume125
Issue number5
DOIs
Publication statusPublished - May 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Watkins, S. K., Zhu, Z., Riboldi, E., Shafer-Weaver, K. A., Stagliano, K. E. R., Sklavos, M. M., ... Hurwitz, A. A. (2015). Retraction: FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. Journal of Clinical Investigation, 125(5), 2179. https://doi.org/10.1172/JCI81878

Retraction : FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. / Watkins, Stephanie K.; Zhu, Ziqiang; Riboldi, Elena; Shafer-Weaver, Kim A.; Stagliano, Katherine E R; Sklavos, Martha M.; Ambs, Stefan; Yagita, Hideo; Hurwitz, Arthur A.

In: Journal of Clinical Investigation, Vol. 125, No. 5, 01.05.2015, p. 2179.

Research output: Contribution to journalArticle

Watkins, SK, Zhu, Z, Riboldi, E, Shafer-Weaver, KA, Stagliano, KER, Sklavos, MM, Ambs, S, Yagita, H & Hurwitz, AA 2015, 'Retraction: FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer', Journal of Clinical Investigation, vol. 125, no. 5, pp. 2179. https://doi.org/10.1172/JCI81878
Watkins, Stephanie K. ; Zhu, Ziqiang ; Riboldi, Elena ; Shafer-Weaver, Kim A. ; Stagliano, Katherine E R ; Sklavos, Martha M. ; Ambs, Stefan ; Yagita, Hideo ; Hurwitz, Arthur A. / Retraction : FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. In: Journal of Clinical Investigation. 2015 ; Vol. 125, No. 5. pp. 2179.
@article{464093d95d4d4704bd6c654995368b0a,
title = "Retraction: FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer",
author = "Watkins, {Stephanie K.} and Ziqiang Zhu and Elena Riboldi and Shafer-Weaver, {Kim A.} and Stagliano, {Katherine E R} and Sklavos, {Martha M.} and Stefan Ambs and Hideo Yagita and Hurwitz, {Arthur A.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1172/JCI81878",
language = "English",
volume = "125",
pages = "2179",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - Retraction

T2 - FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

AU - Watkins, Stephanie K.

AU - Zhu, Ziqiang

AU - Riboldi, Elena

AU - Shafer-Weaver, Kim A.

AU - Stagliano, Katherine E R

AU - Sklavos, Martha M.

AU - Ambs, Stefan

AU - Yagita, Hideo

AU - Hurwitz, Arthur A.

PY - 2015/5/1

Y1 - 2015/5/1

UR - http://www.scopus.com/inward/record.url?scp=84928991751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928991751&partnerID=8YFLogxK

U2 - 10.1172/JCI81878

DO - 10.1172/JCI81878

M3 - Article

AN - SCOPUS:84928991751

VL - 125

SP - 2179

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -